|
|
|
Volumn 5, Issue 2, 1996, Pages 371-393
|
|
Chemotherapy for malignant gliomas
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
1 (2 CHLOROETHYL) 3 (2,6 DIOXO 3 PIPERIDYL) 1 NITROSOUREA;
3 PHENYLACETAMIDO 2,6 PIPERIDINEDIONE;
ANTINEOPLASTIC AGENT;
ANTINEOPLASTON AS2-1;
CARBOPLATIN;
CARMUSTINE;
CHLORMETHINE;
CISPLATIN;
CLADRIBINE;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DOCETAXEL;
ETOPOSIDE;
FLUOROURACIL;
FOTEMUSTINE;
HYDROXYUREA;
IFOSFAMIDE;
LOMUSTINE;
MITOLACTOL;
PACLITAXEL;
PHENYLACETIC ACID;
PROCARBAZINE;
SURAMIN;
TEMOZOLOMIDE;
THIOTEPA;
TIOGUANINE;
TOPOTECAN;
VINCRISTINE;
ASTROCYTOMA;
BONE MARROW TOXICITY;
BONE MARROW TRANSPLANTATION;
CANCER ADJUVANT THERAPY;
CANCER CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CANCER RECURRENCE;
CANCER SURVIVAL;
CLINICAL TRIAL;
DRUG MEGADOSE;
GASTROINTESTINAL SYMPTOM;
GLIOBLASTOMA;
HUMAN;
IMPLANT;
INTERSTITIUM;
INTRAARTERIAL DRUG ADMINISTRATION;
INTRAVENOUS DRUG ADMINISTRATION;
LUNG TOXICITY;
OLIGODENDROGLIOMA;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
REVIEW;
THROMBOCYTOPENIA;
ANTINEOPLASTIC AGENTS;
BRAIN;
BRAIN NEOPLASMS;
CHEMOTHERAPY, ADJUVANT;
DOSE-RESPONSE RELATIONSHIP, DRUG;
GLIOMA;
HUMANS;
METHYLPREDNISOLONE;
NEOPLASM RECURRENCE, LOCAL;
PROCARBAZINE;
SURVIVAL RATE;
|
|
EID: 0030013676
PISSN: 09610421
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (10)
|
|
References (0)
|
